Ferrer Group Inc. Company Profile

11:28 EDT 24th October 2014 | BioPortfolio

Ferrer Grupo offers products of a high scientific standard, according to client needs, together with health training programmes which provide up-to-date information on the constant improvements in the fields of medicine and pharmacology, and maintain direct contact with health professionals, patients and the general public.

Location

Edifici L'illaDiagonal, 549 5a planta
Barcelona
E-08029
Spain

Contact

Phone: 34 93 600 37 00
Fax: 34 93 490 70 78
Email: medicaldepartment@ferrergrupo.com


News Articles [421 Associated News Articles listed on BioPortfolio]

Ferrer begins second Phase III study for Ozenoxacin

Medimetriks Pharmaceuticals has announced that its licensor, Ferrer, has initiated the second Phase III clinical study for Ozenoxacin, a novel bactericidal non-fluorinated quinolone in development for...

Ferrer recruits first patient in second phase III trial of Ozenoxacin for treatment of impetigo

Ferrer, a privately-held Spanish pharmaceutical company, today announces that the first patient has been recruited into a second phase III trial of Ozenoxacin, formulated as a topical treatment for in...

Ferrer initiates second phase III clinical study for Ozenoxacin in adult and paediatric patients with impetigo

Ferrer announced that the first patient has been recruited into a second phase III trial of Ozenoxacin, formulated as a topical treatment for infectious dermatological conditions in adult and paediatr...

UBS Puerto Rico Chairman Miguel Ferrer Leaving Firm, Says Sonn & Erez PLC

MIAMI, June 26, 2014 (GLOBE NEWSWIRE) -- UBS announced today that Miguel A. Ferrer, Chairman of UBS Financial Services of Puerto Rico, is leaving UBS at the end of July, says Sonn & Erez LC, a la...

Ferrer purchases minority share in Genmedica Therapeutics

This purchase coincides with the successful completion of phase I clinical trials on Genmedica’s GMC-253 compound

Medimetriks Pharmaceuticals, Inc. Announces that the Second Phase III Study for Ozenoxacin has been Initiated by Ferrer

FAIRFIELD, N.J., June 12, 2014 /PRNewswire/ -- Medimetriks Pharmaceuticals, Inc. announced today that its licensor, Ferrer, has initiated the second Phase III clinical study for Ozenoxacin, a nov...

Therapy Changes Releases New Guide on Group Therapy

San Diego Clinical Psychologist shares common questions to joining group therapy. San Diego, CA (PRWEB) September 02, 2014 Today, Therapy Changes released a new guide titled, “Is Group Therapy Righ...

Alexza Pharmaceuticals announces availability of ADASUVE inhalation powder in Guatemala

Alexza Pharmaceuticals, Inc. today announced that ADASUVE inhalation powder, pre-dispensed (loxapine) is now available in Guatemala. This approval represents the first ADASUVE approval in Latin Americ...

PubMed Articles [2363 Associated PubMed Articles listed on BioPortfolio]

The Ontogeny of the Motivation That Underlies In-Group Bias.

Humans demonstrate a clear bias toward members of their own group over members of other groups in a variety of ways. It has been argued that the motivation underlying this in-group bias in adults may ...

Study About the Effects of Different Fitness Sports on Cognitive Function and Emotion of the Aged.

The aim of the study was to explore the effects of different fitness sports on cognitive function and emotion of the aged people. A total of 150 subjects aged between 60 and 70 were recruited from She...

The Attenuation of Lung Ischemia Reperfusion Injury by Oxymatrine.

To investigate the protective effects of oxymatrine (OMT) on lung ischemia reperfusion injury (LIRI) in rabbits, models of LIRI in rabbit were used. Thirty-two rabbits were randomly divided into four ...

The effect of preemptive perianal ropivacaine and ropivacaine with dexmedetomidine on pain after hemorrhoidectomy: a prospective, randomized, double-blind, placebo-controlled study.

The objective of this study was to assess the efficacy of perianal infiltration of ropivacaine and dexmedetomidine added to ropivacainein in the relief of pain after hemorrhoidectomy. Patients in grou...

The Effects of Within- and Between-Group Competition on Trust and Trustworthiness among Acquaintances.

Several studies have indicated that between-group competition is a key stimulator of trust and trustworthiness. Another important but neglected type of competition may also affect trust and trustworth...

Clinical Trials [1357 Associated Clinical Trials listed on BioPortfolio]

Does Cognitive Rehabilitation Demonstrate Benefits in the Group Setting With People Whom Have Experienced Brain Injury?

The purpose of this study is to determine whether there is benefit from providing cognitive rehabilitation in the group setting. Several standardized tools will be used to measure progres...

Short Term Group Therapy for OCD

Assessing OCD before and after group therapy

Psychological Prevention of Internalizing Disorders

The purpose of this study is to determine whether cognitive-behavioral group prevention (CBT-G) for german children is effective and to what extent parental group training moderates outcom...

Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine -

The purpose of the study is to verify superiority of the lafutidine group over the placebo group and non-inferiority to the famotidine group in terms of endoscopic healing rate of the pati...

Clinical Trial of Donepezil Between the Naive Group and the Switching Group

To compare the clinical efficacy of donepezil between the naive group and the switching group.

Companies [1424 Associated Companies listed on BioPortfolio]

Ferrer Group Inc.

Ferrer Grupo offers products of a high scientific standard, according to client needs, together with health training programmes which provide up-to-date information on the constant improvements in the...

Ferrer Freeman & Company, LLC

Ferrer Freeman & Company, LLC, is a private equity firm located in Greenwich, CT focuses exclusively on growth capital investments in the healthcare industry. Since its founding i...

DiaGenic ASA & Ferrer inCode

DiaGenic is an innovative Norwegian biotechnology company that seeks to create value for patients, partners, and investors by developing new and more patient friendly methods for ...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

More Information about "Ferrer Group Inc." on BioPortfolio

We have published hundreds of Ferrer Group Inc. news stories on BioPortfolio along with dozens of Ferrer Group Inc. Clinical Trials and PubMed Articles about Ferrer Group Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ferrer Group Inc. Companies in our database. You can also find out about relevant Ferrer Group Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record